These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1741548

  • 1. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
    Horvath CJ, Kaplan JE, Malik AB.
    Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites.
    Burhop KE, van der Zee H, Bizios R, Kaplan JE, Malik AB.
    Am Rev Respir Dis; 1986 Sep; 134(3):548-54. PubMed ID: 3752711
    [Abstract] [Full Text] [Related]

  • 3. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [Abstract] [Full Text] [Related]

  • 4. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW, Lefferts PL, Blair IA, Snapper JR.
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor increases lung vascular permeability to protein.
    Burhop KE, Garcia JG, Selig WM, Lo SK, van der Zee H, Kaplan JE, Malik AB.
    J Appl Physiol (1985); 1986 Dec; 61(6):2210-7. PubMed ID: 3804927
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function.
    Kruse-Elliott KT, Dodam JR, Johnson LW, Olson NC.
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H761-70. PubMed ID: 1415600
    [Abstract] [Full Text] [Related]

  • 7. Thrombin-induced leukopenia and thrombocytopenia are attenuated by PAF antagonist WEB 2086.
    van der Zee H, Moon DG, Kaplan JE, Gudewicz PW, Fenton J.
    J Lab Clin Med; 1991 Apr; 117(4):305-12. PubMed ID: 1901342
    [Abstract] [Full Text] [Related]

  • 8. The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep.
    Wheeler AP, Hardie WD, Bernard GR.
    Am Rev Respir Dis; 1992 Mar; 145(3):632-9. PubMed ID: 1546845
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary microcirculatory responses to leukotrienes B4, C4 and D4 in sheep.
    Noonan TC, Kern DF, Malik AB.
    Prostaglandins; 1985 Sep; 30(3):419-34. PubMed ID: 2997844
    [Abstract] [Full Text] [Related]

  • 10. Effect of prostacyclin on pulmonary vascular response to thrombin in awake sheep.
    Perlman MB, Lo SK, Malik AB.
    J Appl Physiol (1985); 1986 Feb; 60(2):546-53. PubMed ID: 3512510
    [Abstract] [Full Text] [Related]

  • 11. Thrombin-induced alterations in lung fluid balance in awake sheep.
    Lo SK, Perlman MB, Niehaus GD, Malik AB.
    J Appl Physiol (1985); 1985 May; 58(5):1421-7. PubMed ID: 3997709
    [Abstract] [Full Text] [Related]

  • 12. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW.
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG, Barnes PJ, Evans TW.
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [Abstract] [Full Text] [Related]

  • 14. Leukocyte repletion reverses protective effect of neutropenia in thrombin-induced increase in lung vascular permeability.
    Lo SK, Garcia-Szabo RR, Malik AB.
    Am J Physiol; 1990 Jul; 259(1 Pt 2):H149-55. PubMed ID: 2375401
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor.
    Chang SW, Ohara N, Kuo G, Voelkel NF.
    Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary transvascular fluid and protein exchange after thrombin-induced microembolism. Differential effects of cyclooxygenase inhibitors.
    Johnson A, Malik AB.
    Am Rev Respir Dis; 1985 Jul; 132(1):70-6. PubMed ID: 3925828
    [Abstract] [Full Text] [Related]

  • 17. Ibuprofen prevents thrombin-induced lung vascular injury: mechanism of effect.
    Perlman MB, Johnson A, Malik AB.
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H605-14. PubMed ID: 3030141
    [Abstract] [Full Text] [Related]

  • 18. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.
    Horvath CJ, Ferro TJ, Jesmok G, Malik AB.
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9219-23. PubMed ID: 3143114
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV, Eberhart SW, Robinson NE, Rice R, Gray PR.
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [Abstract] [Full Text] [Related]

  • 20. Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep.
    Koizumi T, Kubo K, Kobayashi T, Sekiguchi M.
    J Appl Physiol (1985); 1992 Aug; 73(2):618-24. PubMed ID: 1399989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.